Frontiers in Oncology (Aug 2017)

Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients

  • Yuenv Wu,
  • Yuenv Wu,
  • Carmen Mariana Aanei,
  • Carmen Mariana Aanei,
  • Sanae Kesr,
  • Sanae Kesr,
  • Tiphanie Picot,
  • Tiphanie Picot,
  • Denis Guyotat,
  • Denis Guyotat,
  • Lydia Campos Catafal,
  • Lydia Campos Catafal

DOI
https://doi.org/10.3389/fonc.2017.00164
Journal volume & issue
Vol. 7

Abstract

Read online

The pathogenic role of mesenchymal stromal cells (MSCs) in myelodysplastic syndromes (MDS) development and progression has been investigated by numerous studies, yet, it remains controversial in some aspects (1, 2). In the present study, we found distinct features of MSCs from low-risk (LR)-MDS stromal microenvironment as compared to those from healthy subjects. At the molecular level, focal adhesion kinase, a key tyrosine kinase in control of cell proliferation, survival, and adhesion process, was found profoundly suppressed in expression and activation in LR-MDS MSC. At a functional level, LR-MDS MSCs showed impaired growth and clonogenic capacity, which were independent of cellular senescence and apoptosis. The pro-adipogenic differentiation and attenuated osteogenic capacity along with reduced SDF-1 expression could be involved in creating an unfavorable microenvironment for hematopoiesis. In conclusion, our experiments support the theory that the stromal microenvironment is fundamentally altered in LR-MDS, and these preliminary data offer a new perspective on LR-MDS pathophysiology.

Keywords